Clinical Trial Update: BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating BMX-001 combined with paclitaxel in adults with advanced, recurrent, metastatic ovarian or endometrial cancer; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Ovarian Cancer

Drugs mentioned

• BMX-001
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: BioMimetix JV, LLC | Conditions: Ovarian Neoplasms, Endometrial Cancer, Endometrial Neoplasm | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING